Literature DB >> 18547969

Management of malignant glioma--quo vadis?

Roger Stupp, Andreas F Hottinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18547969     DOI： 10.1159/000134024

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  3 in total

1.  Hypofractionated stereotactic reirradiation of recurrent glioblastomas : a beneficial treatment option after high-dose radiotherapy?

Authors:  Emmanouil Fokas; Ulrich Wacker; Markus W Gross; Martin Henzel; Elitsa Encheva; Rita Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

2.  Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours.

Authors:  Jerzy Trojan; Yuexin X Pan; Ming X Wei; Adama Ly; Alexander Shevelev; Maciej Bierwagen; Marie-Yvonne Ardourel; Ladislas A Trojan; Alvaro Alvarez; Christian Andres; Maria C Noguera; Ignacio Briceno; Beatriz H Aristizabal; Heliodor Kasprzak; Huynh T Duc; Donald D Anthony
Journal:  Chemother Res Pract       Date:  2012-02-14

3.  A new functional classification system (FGA/B) with prognostic value for glioma patients.

Authors:  Katharina Friedlein; Yavor Bozhkov; Nirjhar Hore; Andreas Merkel; Björn Sommer; Sebastian Brandner; Michael Buchfelder; Nicolai E Savaskan; Ilker Y Eyüpoglu
Journal:  Sci Rep       Date:  2015-07-21       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.